Article
Phenotype of CYP2C19 and CYP3A4 by determination of omeprazole and its two main metabolites in plasma using liquid chromatography with liquid-liquid extraction.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences - 25 Nov 2002
González Héctor M, Romero Elba M, Chavez Teresa de J, Peregrina A Aaron, Quezada Víctor, Hoyo-Vadillo Carlos
Abstract excerpt
We present a new simple and reliable HPLC method for measuring omeprazole and its two main metabolites in plasma. This can be used for studying CYP2C19 and CYP3A4 genetic polymorphisms using omeprazole as the probe drug. Omeprazole, hydroxyomeprazole and omeprazole sulfone were extracted from plasma samples with phosphate buffer and dichloromethane-ether (95:5). HPLC separation was achieved using an Ultrasphere...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
